Treatments | Mean mortality (%) of IJs at different intervals (h) | Cumulative mean | |||
---|---|---|---|---|---|
24 | 48 | 72 | % IJs mortality | % IJs survival | |
100 IJs + Quinalphos 25 EC @ 0.0175% | 14.8 (21.1)* | 20.5 (26.8) | 22.0 (27.8) | 19.1 | 80.9 |
100 IJs + Quinalphos 25 EC @ 0.035% | 18.5 (25.4) | 25.1 (30.0) | 29.3 (32.7) | 24.3 | 75.7 |
100 IJs + Quinalphos 25 EC @ 0.07% | 30.0 (33.1) | 40.3 (39.3) | 47.6 (43.6) | 39.3 | 60.7 |
100 IJs + Dichlorvos 76 EC @ 0.025% | 15.0 (22.7) | 20.8 (27.0) | 23.3 (28.7) | 19.7 | 80.3 |
100 IJs + Dichlorvos 76 EC @ 0.05% | 20.1 (26.5) | 31.0 (33.7) | 37.1 (37.5) | 29.4 | 70.6 |
100 IJs + Dichlorvos 76 EC @ 0.1% | 34.8 (36.1) | 50.3 (45.1) | 61.1 (50.9) | 48.7 | 51.3 |
100 IJs + Azadirachtin @ 0.125% | 14.5 (22.3) | 19.3 (26.0) | 21.0 (27.1) | 18.2 | 81.8 |
100 IJs + Azadirachtin @ 0.25% | 16.3 (23.7) | 23.6 (29.0) | 27.8 (31.7) | 22.5 | 77.5 |
100 IJs + Azadirachtin @ 0.5% | 28.5 (32.1) | 37.0 (37.4) | 42.3 (40.5) | 35.9 | 64.1 |
Untreated control (100 IJs only) | 4.1 (11.6) | 4.1 (11.6) | 4.1 (11.6) | 4.1 | 95.9 |